Search Results - "Selleslags, Jean"
-
1
Multifactorial Approach to Predicting Resistance to Anthracyclines
Published in Journal of clinical oncology (20-04-2011)“…Validated biomarkers predictive of response/resistance to anthracyclines in breast cancer are currently lacking. The neoadjuvant Trial of Principle (TOP)…”
Get full text
Journal Article -
2
Fulvestrant (Faslodex™) in advanced breast cancer: clinical experience from a Belgian cooperative study
Published in Breast cancer research and treatment (01-05-2008)“…Fulvestrant (Faslodex™) is a new estrogen receptor (ER) antagonist with no agonist effects that is licensed for the treatment of postmenopausal women with…”
Get full text
Journal Article Web Resource -
3
A Phase I and Pharmacokinetic Study of Docetaxel Administered in Combination with Continuous Intravenous Infusion of 5-Fluorouracil in Patients with Advanced Solid Tumors
Published in Clinical cancer research (01-01-2000)“…Encouraged by preclinical synergism between docetaxel and 5-fluorouracil (5FU), we conducted a Phase I study of docetaxel in combination with continuous i.v…”
Get full text
Journal Article -
4
Oxaliplatin/5fluorouracil-based chemotherapy was active and well tolerated in heavily pretreated patients with ovarian carcinoma
Published in Archives of gynecology and obstetrics (01-11-2008)“…Objectives The prognosis of patients with platinum refractory disease is dismal. We present data from heavily pretreated patients to whom the folinic acid,…”
Get full text
Journal Article -
5
Influence of Amifostine on the Toxicity and Pharmacokinetics of Docetaxel in Metastatic Breast Cancer Patients
Published in Clinical cancer research (01-01-2002)“…Preclinical studies suggest that amifostine could protect against toxicities induced by taxoids. We conducted a clinical and pharmacokinetic pilot study to…”
Get full text
Journal Article -
6
Influence of amifostine on the toxicity and pharmacokinetics of docetaxel in metastatic breast cancer patients: A pilot study
Published in Clinical cancer research (2002)“…Preclinical studies suggest that amifostine could protect against toxicities induced by taxoids. We conducted a clinical and pharmacokinetic pilot study to…”
Get full text
Journal Article